CASE REPORT
Psychoneuroimmunological aspects of cardiovascular diseases: a preliminary report
Submission date: 2015-11-04
Final revision date: 2015-12-31
Acceptance date: 2016-02-16
Publication date: 2016-07-15
Cent Eur J Immunol 2016;41(2):209-216
KEYWORDS
ABSTRACT
Aim of the study: Due to their prevalence and negative social effects, cardiovascular diseases belong to a group of civilization diseases. Previous research suggests comorbidity of heart diseases, mood disorders and impaired cognitive functioning. The aim of this study was to evaluate the psychoneuroimmunological aspects of functioning in patients diagnosed with cardiovascular diseases.
Material and methods: Ten persons, mean age 48.2 years old, diagnosed with primary hypertension, were studied. All of them were treated with beta blockers and ACE inhibitors with unsuccessful therapeutic effect. This group also included 4 subjects with heart rate disturbances. The control group included 10 clinically healthy volunteers in mean age 46.8. All participants had 24-hour ECG monitoring with Holter method in order to evaluate the autonomic activity with time and frequency domain analysis (heart rate variability). Patients also underwent neuropsychological assessment of quality of life and personality traits (EQ-5D, NEO-PI-R, PSS10, SWLS, MHLC). Quantitative evaluation of immune system parameters included: TCD3, TCD4, CD8, CD16/CD56, CD19, HLA-DR+.
Results: The cardiovascular disease group showed significantly lower time and frequency domain parameters (p < 0.05) except low/high frequency (LF/HF) power ratio. The heart rhythm disorder group demonstrated significant relationships such as: Quality of life with Total Power of HRV and day-time LF/HF ratio, pNN50 and rMSSD – negative correlation.
Conclusions: 1. In cardiovascular disease patients, activity of the autonomic nervous system is significantly reduced. 2. Impaired modulation of the autonomic nervous system activity affects mood and decreases quality of life. 3. In patients with heart rhythm disturbances, increased sympathetic nervous system activity affects prolonged tension and the immune response.
Material and methods: Ten persons, mean age 48.2 years old, diagnosed with primary hypertension, were studied. All of them were treated with beta blockers and ACE inhibitors with unsuccessful therapeutic effect. This group also included 4 subjects with heart rate disturbances. The control group included 10 clinically healthy volunteers in mean age 46.8. All participants had 24-hour ECG monitoring with Holter method in order to evaluate the autonomic activity with time and frequency domain analysis (heart rate variability). Patients also underwent neuropsychological assessment of quality of life and personality traits (EQ-5D, NEO-PI-R, PSS10, SWLS, MHLC). Quantitative evaluation of immune system parameters included: TCD3, TCD4, CD8, CD16/CD56, CD19, HLA-DR+.
Results: The cardiovascular disease group showed significantly lower time and frequency domain parameters (p < 0.05) except low/high frequency (LF/HF) power ratio. The heart rhythm disorder group demonstrated significant relationships such as: Quality of life with Total Power of HRV and day-time LF/HF ratio, pNN50 and rMSSD – negative correlation.
Conclusions: 1. In cardiovascular disease patients, activity of the autonomic nervous system is significantly reduced. 2. Impaired modulation of the autonomic nervous system activity affects mood and decreases quality of life. 3. In patients with heart rhythm disturbances, increased sympathetic nervous system activity affects prolonged tension and the immune response.
REFERENCES (47)
1.
Kreatsoulas C, Anand SS (2010): The impact of social determinants on cardiovascular disease. Can J Cardiol 26: 8C-13C.
2.
Thayer JF, Lane RD (2009): Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev 33: 81-88.
3.
Musselman DL, Evans DL, Nemeroff CB (1998): The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55: 580-592.
4.
Mancia G, Fagard R, Narkiewicz K, et al. (2013): Wytyczne ESH/ESC dotyczące postępowania w nadciśnieniu tętniczym w 2013 roku. Arter Hypertens 17: 69-168.
5.
Heras MM, Rodríguez N del C, González JF (2012): The renin-angiotensin-aldosterone system in renal and cardiovascular disease and the effects of its pharmacological blockade.
7.
Yildirir A, Batur MK, Oto A (2002): Hypertension and arrhythmia: blood pressure control and beyond. Eurpace 4: 175-182.
8.
PhD NM. Cardiovascular Diseases: Nutritional and Therapeutic Interventions. CRC Press; 2013.
9.
Ammirati E, Cianflone D, Vecchio V, et al. (2012): Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. J Am Heart Assoc 1: 27-41.
10.
Libby P, Ridker PM, Maseri A (2002): Inflammation and atherosclerosis. Circulation 105: 1135-1143.
11.
Ribatti D, Crivellato E, Vacca A (2006): Miller’s seminal studies on the role of thymus in immunity. Clin Exp Immunol 144: 371-375.
12.
Dąbrowski M, Dąbrowski M, Stankiewicz W (2011): The thymus in neuro-endocrine-immune network. Centr Eur J Immunol 188-192.
14.
Guzik TJ, Hoch NE, Brown KA, et al. (2007): Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449-2460.
15.
Madhur MS, Harrison DG (2013): Senescent T cells and hypertension: new ideas about old cells. Hypertension 62: 13-15.
16.
Deschaux P, Rouabhia M (1987): The thymus. Key organ between endocrinologic and immunologic systems. Ann N Y Acad Sci 496: 49-55.
17.
Asadi-Lari M, Tamburini M, Gray D (2004): Patients’ needs, satisfaction, and health related quality of life: Towards a comprehensive model. Health Qual Life Outcomes 2: 32.
18.
Roditi D, Robinson ME (2011): The role of psychological interventions in the management of patients with chronic pain. Psychol Res Behav Manag 4: 41-49.
19.
Hlatky MA, Vaughn WK (1996): Quality of life in patients with supraventricular arrhythmia. Circulation 94: 1491-1493.
20.
AbuRuz ME, Alaloul F, Saifan A, et al. (2015): Quality of life for saudi patients with heart failure: a cross-sectional correlational study. Glob J Health Sci 8: 45752.
21.
Gillie BL, Thayer JF (2014): Individual differences in resting heart rate variability and cognitive control in posttraumatic stress disorder. Front Psychol 5: 758.
22.
McCorry LK (2007): Physiology of the autonomic nervous system. Am J Pharm Educ 2007; 71.
23.
Hovland A, Pallesen S, Hammar Å, et al. (2012): The relationships among heart rate variability, executive functions, and clinical variables in patients with panic disorder. Int J Psychophysiol 86: 269-275.
24.
Kim DH, Lipsitz LA, Ferrucci L, et al. (2006): Association between reduced heart rate variability and cognitive impairment in older disabled women in the community: women’s health and aging study I. J Am Geriatr Soc 54: 1751-1757.
25.
Garin O, Ferrer M, Pont À, et al. (2008): Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 18: 71-85.
26.
Ski CF, Jelinek M, Jackson AC, et al. (2015): Psychosocial interventions for patients with coronary heart disease and depression: A systematic review and meta-analysis. Eur J Cardiovasc Nurs doi:10.1177/1474515115613204.
27.
Szyguła-Jurkiewicz B, Kowalska M, Mościński M (2011): Jakość życia jako element oceny stanu zdrowia i efektywności leczenia chorych ze schorzeniami układu sercowo-naczyniowego. Folia Cardiol 6: 62-71.
28.
Dardiotis E, Giamouzis G, Mastrogiannis D, et al. (2012): Cognitive impairment in heart failure, cognitive impairment in heart failure. Cardiol Res Pract 2012: e595821.
29.
Tracy LM, Ioannou L, Baker KS, et al. (2016): Gibson SJ, Georgiou-Karistianis N, Giummarra MJ. Meta-analytic evidence for decreased heart rate variability in chronic pain implicating parasympathetic nervous system dysregulation. Pain 157: 7-29.
30.
Chalmers JA, Quintana DS, Abbott MJ-A, Kemp AH (2014): Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Affect Disord Psychosom Res 5: 80.
31.
Kreibig SD (2010): Autonomic nervous system activity in emotion: A review. Biol Psychol 84: 394-421.
32.
Kupper N, Pedersen SS, Höfer S, et al. (2013): Cross-cultural analysis of type D (distressed) personality in 6222 patients with ischemic heart disease: a study from the International HeartQoL Project. Int J Cardiol 166: 327-333.
33.
Jokela M, Pulkki-Råback L, Elovainio M, Kivimäki M (2014): Personality traits as risk factors for stroke and coronary heart disease mortality: pooled analysis of three cohort studies.
35.
Khayyam-Nekouei Z, Neshatdoost H, Yousefy A, et al. (2013): Psychological factors and coronary heart disease. ARYA Atheroscler 9: 102-111.
36.
Omeje O, Nebo C (2011): The influence of locus control on adherence to treatment regimen among hypertensive patients. Patient Prefer Adherence 5: 141-148.
37.
Hawthorne MH, Hixon ME (1993): Functional status, mood disturbance and quality of life in patients with heart failure. Prog Cardiovasc Nurs 9: 22-32.
38.
Straburzyńska-Migaj E, Ochotny R, Wachowiak-Baszyńska A, et al. (2005): Cytokines and heart rate variability in patients with chronic heart failure. Kardiol Pol 63: 478-485.
39.
Kenney MJ, Ganta CK (2014): Autonomic nervous system and immune system interactions. Compr Physiol 2014; 4: 1177-1200.
40.
Papaioannou V, Pneumatikos I, Maglaveras N (2013): Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: current strengths and limitations. Front Physiol 2013; 4: 174.
41.
Janszky I, Ericson M, Lekander M, et al. (2004): Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-428.
42.
Papaioannou VE, Verkerk AO, Amin AS, de Bakker JM (2013): Intracardiac origin of heart rate variability, pacemaker funny current and their possible association with critical illness. Curr Cardiol Rev 9: 82-96.
43.
Norman RA, Dzielak DJ (1986): Immunological dysfunction and enhanced sympathetic activity contribute to the pathogenesis of spontaneous hypertension. J Hypertens Suppl 4: S437-S439.
44.
Albus C, Ladwig K-H, Herrmann-Lingen C (2014): Psychocardiology: clinically relevant recommendations regarding selected cardiovascular diseases. Dtsch Med Wochenschr 1946 139: 596-601.
45.
Cuffee Y, Ogedegbe C, Williams NJ, et al. (2014): Psychosocial risk factors for hypertension: an update of the literature. Curr Hypertens Rep 16: 483.
46.
Gouin JP, Wenzel K, Boucetta S, et al. (2015): High-frequency heart rate variability during worry predicts stress-related increases in sleep disturbances. Sleep Med 16: 659-664.
47.
Moryś JM, Bellwon J, Jeżewska M, et al. (2015): The evaluation of stress coping styles and type D personality in patients with coronary artery disease. Kardiol Pol 73: 557-566.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
